Join to View Full Profile
55 Fruit StPathology Associates Wrn 2Boston, MA 02114
Phone+1 617-726-2967
Fax+1 617-726-7474
Dr. Wu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Chin-Lee Wu is a pathologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from Southern Medical University and has been in practice 34 years. He specializes in genitourinary pathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in genitourinary pathology. He has more than 200 publications and over 15000 citings.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Southern Medical UniversityClass of 1983
Certifications & Licensure
MA State Medical License 1998 - 2027
American Board of Pathology Anatomic Pathology
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- Pathologic Upgrading in Biopsy Grade Group 1, PI-RADS ≥ 3 Prostate Cancer: Factors Associated With Clinically Significant Disease on Radical Prostatectomy.Alfred A Barney, Shulin Wu, Adam S Feldman, Chin-Lee Wu, Douglas M Dahl
Clinical Genitourinary Cancer. 2026-06-01 - Cribriform/Intraductal carcinoma exhibits superior prognostic value over Gleason pattern 4 percentage and tertiary pattern 5 in Gleason pattern 4 prostate cancer.Chaojiang Chen, Xiaoyang Liu, Shulin Wu, Sharron X Lin, Adam S Feldman
World Journal of Urology. 2026-05-12 - Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.David D Yang, Aya Abdelnaser, Alexander J Haas, Jeremiah Wala, Alfred A Barney
Clinical Cancer Research. 2026-05-11
Press Mentions
Gene-Expression Signature May Signify Risk for Recurrence, Metastasis in Prostate CancerApril 15th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
